MODIVCARE ALERT: Bragar Eagel & Squire, P.C. Continues Investigating ModivCare, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

Core Viewpoint - Bragar Eagel & Squire, P.C. is investigating potential claims against ModivCare, Inc. on behalf of long-term stockholders following a class action complaint alleging misleading statements and omissions regarding the company's cash flow stability [1][2]. Group 1: Legal Investigation - A class action complaint was filed against ModivCare on January 29, 2025, with a class period from November 3, 2022, to September 15, 2024 [1]. - The investigation focuses on whether ModivCare's board of directors breached their fiduciary duties to the company [1]. Group 2: Stock Performance Impact - During the class period, ModivCare allegedly made misleading statements about its contracts' ability to stabilize cash flow, leading to significant stock price declines as the truth emerged [2]. - On September 16, 2024, ModivCare revised its 2024 Adjusted EBITDA guidance from $185-$195 million to $170-$180 million, resulting in a stock price drop of $1.40, or nearly 10%, from $14.12 to $12.72 per share [2].